Search Results

You are looking at 71 - 80 of 117 items for :

  • "consolidation therapy" x
  • Refine by Access: All x
Clear All
Full access

Prevention, Diagnosis, and Treatment of Invasive Fungal Infections in Patients with Cancer and Neutropenia

Thomas A. Cumbo and Brahm H. Segal

myeloid leukemia: a Southwest oncology group study (9031) . Blood 1998 ; 91 : 3607 – 3615 . 98 Heil G Hoelzer D Sanz MA . A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation

Full access

Novel Therapies in the Treatment of Multiple Myeloma

Jacob P. Laubach, Constantine S. Mitsiades, Anuj Mahindra, Robert L. Schlossman, Teru Hideshima, Dharminder Chauhan, Nicole A. Carreau, Irene M. Ghobrial, Noopur Raje, Nikhil C. Munshi, Kenneth C. Anderson, and Paul G. Richardson

. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure . J Clin Oncol 2009 ; 27 : 1788 – 1793 . 41 Barlogie B Tricot G

Full access

The Role of Maintenance Therapy in the Treatment of Multiple Myeloma

Ashraf Z. Badros

; 111 : 1805 – 1810 . 16. Spencer A Prince HM Roberts AW . Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure

Full access

Lung Cancer Survivorship: Physical, Social, Emotional, and Medical Needs of NSCLC Survivors

Melinda L. Hsu, Matthew Z. Guo, Sarah Olson, Cyd Eaton, Mary Boulanger, Michelle Turner, Mattea E. Miller, Anna Nguyen, Karol Szczepanek, Rahul Shenolikar, and Josephine L. Feliciano

pemetrexed following treatment with pembrolizumab, carboplatin, and pemetrexed) and consolidation therapy (ie, durvalumab following treatment with definitive chemoradiation) were not counted as additional lines of therapy. These distinctions were used to

Full access

Care Patterns and Barriers to Outpatient Care for Adults With AML Following Intensive Chemotherapy at NCCN Member Institutions

Anna B. Halpern, Jessica M. Sugalski, Lindsey Bandini, Megan Othus, F. Marc Stewart, and Roland B. Walter

patients early less frequently. Table 1. Formal Discharge Criteria for Early Hospital Discharge (N=5) Practice Patterns Following Postremission Chemotherapy We next examined how centers deliver care following postremission (“consolidation

Full access

Acute Lymphoblastic Leukemia

Joseph C. Alvarnas, Patrick A. Brown, Patricia Aoun, Karen Kuhn Ballen, Naresh Bellam, William Blum, Michael W. Boyer, Hetty E. Carraway, Peter F. Coccia, Steven E. Coutre, Jennifer Cultrera, Lloyd E. Damon, Daniel J. DeAngelo, Dan Douer, Haydar Frangoul, Olga Frankfurt, Salil Goorha, Michael M. Millenson, Susan O'Brien, Stephen H. Petersdorf, Arati V. Rao, Stephanie Terezakis, Geoffrey Uy, Meir Wetzler, Andrew D. Zelenetz, Maoko Naganuma, and Kristina M. Gregory

-negative ALL can be further categorized as having high-risk disease, which may be particularly helpful when consolidation therapy with allogeneic HSCT is being considered. High risk is defined as having any of the following poor-risk factors: elevated WBC count

Full access

Biologic Agents in the Management of Hodgkin Lymphoma

Armin Rashidi and Nancy L. Bartlett

AETHERA study ( ClinicalTrials.gov identifier: NCT01100502), evaluating BV as consolidation therapy after auto-SCT in high-risk patients. 40 Patients had primary refractory disease, or experienced disease relapse either less than 12 months after

Full access

Controversies Regarding Use of Myeloid Growth Factors in Leukemia

Jacqueline N. Poston and Pamela S. Becker

; 106 : 27 – 34 . 29. Heil G Hoelzer D Sanz MA . A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia . Blood 1997

Full access

Addition of Definitive Radiotherapy to Chemotherapy in Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer

Vivek Verma, Pamela K. Allen, Charles B. Simone II, Hiram A. Gay, and Steven H. Lin

2014 ; 32 : 3824 – 3830 . 11. Gomez DR Blumenschein GR Jr Lee JJ . Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first

Full access

Role of Alternative Donor Allogeneic Transplants in the Therapy of Acute Myeloid Leukemia

Hany Elmariah and Keith W. Pratz

Background For 40 years, standard therapy for acute myeloid leukemia (AML) has remained infusional cytarabine/anthracycline–based induction chemotherapy to achieve remission, followed typically by high-dose cytarabine consolidative therapy to